Adverse maternal and fetal outcomes and deaths related to preeclampsia and eclampsia in Haiti

Pregnancy Hypertension

Volumn 4, Issue 4, 2014, Pages 279-286

  Raghuraman, Nandini ^a   March, Melissa I ^a,b,c   Hacker, Michele R ^a,c   Modest, Anna Merport ^a   Wenger, Julia ^c   Narcisse, Rulx ^d   Louis David, Jean ^d   Scott, Jennifer ^a,e   Rana, Sarosh ^a,b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Hospital Albert Schweitzer   (Haïti)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adverse maternal and perinatal outcomes; Eclampsia; Haiti; Preeclampsia

Indexed keywords

ADULT; ADVERSE OUTCOME; AGE; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECLAMPSIA; FEMALE; FETUS; FETUS OUTCOME; HAITI; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MEDICAL RECORD REVIEW; NULLIPARA; PREECLAMPSIA; PREGNANCY OUTCOME; PRENATAL CARE; RETROSPECTIVE STUDY; RURAL AREA; SOLUTIO PLACENTAE; STILLBIRTH;

EID: 84916898162     PISSN: 22107789     EISSN: 22107797     Source Type: Journal    
DOI: 10.1016/j.preghy.2014.09.002     Document Type: Article

References (18)

1. World Health Report 2005 Make every mother and child count 2005 World Health Organization Geneva
2. Bulletins-Obstetrics ACoP. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99(1):159-67.
3. B.M. Sibai Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia Semin Perinatol 35 5 2011 292 296
4. Vigil-De Gracia P, Reyes Tejada O, Calle Minaca A, Tellez G, Chon VY, Herrarte E, et al. Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial. Am J Obstet Gynecol 2013; 209(5):425. e1-8.
5. Morisaki N, Togoobaatar G, Vogel J, Souza J, Rowland Hogue C, Jayaratne K, et al. Risk factors for spontaneous and provider-initiated preterm delivery in high and low Human Development Index countries: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 2014; 121(Suppl. 1):101-9.
6. Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk Factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PloS One 2014;9(3):e91198. PubMed PMID: 24657964. Pubmed Central PMCID: 3962376.
7. T. Firoz, H. Sanghvi, M. Merialdi, and P. von Dadelszen Pre-eclampsia in low and middle income countries Best Pract Res Clin Obstet Gynaecol 25 4 2011 537 548
8. von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Cote AM, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011;377(9761):219-27.
9. Payne BA, Hutcheon JA, Ansermino JM, Hall DR, Bhutta ZA, Bhutta SZ, et al. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study. PLoS Med 2014; 11(1):e1001589. PubMed PMID: 24465185. Pubmed Central PMCID: 3897359.
10. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125(7):911-9. PubMed PMID: 22261192. Pubmed Central PMCID: 3319742.
11. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods, and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global burden of disease and risk factors. Washington (DC); 2006.
12. M.J. Small, T. Kershaw, R. Frederic, C. Blanc, D. Neale, and J. Copel Characteristics of preeclampsia- and eclampsia-related maternal death in rural Haiti J Maternal-Fetal Neonatal Med 18 5 2005 343 348
13. E. Abalos, C. Cuesta, A.L. Grosso, D. Chou, and L. Say Global and regional estimates of preeclampsia and eclampsia: a systematic review Eur J Obstet Gynecol Reprod Biol 170 1 2013 1 7
14. A.G. Moore, H. Young, J.M. Keller, L.R. Ojo, J. Yan, and T.A. Simas Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia J Maternal-Fetal Neonatal Med 25 12 2012 2651 2657
15. Chaiworapongsa T, Romero R, Korzeniewski SJ, Kusanovic JP, Soto E, Lam J, et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol 2013; 208(4):287. e1-e15.
16. T. Chaiworapongsa, R. Romero, S.J. Korzeniewski, J.M. Cortez, A. Pappas, and A.L. Tarca Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study J Maternal-Fetal Neonatal Med 27 2 2014 132 144
17. L.C. Chappell, S. Duckworth, P.T. Seed, M. Griffin, J. Myers, and L. Mackillop Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study Circulation 128 19 2013 2121 2131
18. V.L. Katz, R. Farmer, and J.A. Kuller Preeclampsia into eclampsia: toward a new paradigm Am J Obstet Gynecol 182 6 2000 1389 1396